Search

Reset

Status

Medical Condition

Displaying 1 - 2 of 2

Drug study looking at effects of dapagliflozin on patients with Heart Failure and Preserved Ejection Fraction and diabetes or pre-diabetes.

Condition: Heart Disease
Investigator: Mathew Maurer, MD
Status: Closed
A drug study looking at the effects of 10 mg Dapagliflozin vs. Placebo in patients with Heart Failure and Preserved Ejection Fraction (HFpEF) with either diabetes or pre-diabetes.
Read More

A study for patients with Type 2 Diabetes Mellitus with coronary artery disease using study drug Ticagrelor

Condition: Heart Disease / Arterial Disease
Investigator: Melvin Weiss, MD, FACC
Status: Closed
The purpose of this study is to see if a new medication called ticagrelor given twice daily ismore effective than aspirin alone in preventing the occurrence of heart attack, stroke and/ordeath due to cardiovascular events in patients who have type 2 diabetes. Ticagrelor is anantiplatelet therapy (stop platelets from clumping…
Read More